HGERS
VRTX icon

Householder Group Estate & Retirement Specialist’s Vertex Pharmaceuticals VRTX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44
Closed -$20K – 1212
2024
Q3 		$20K Sell
44
-5
-10% -$2.4K 0.01% 683
2024
Q2 		$22K Buy
49
+37
+308% +$16.1K 0.01% 667
2024
Q1 		$5.02K Sell
12
-5
-29% -$2.11K ﹤0.01% 928
2023
Q4 		$6K Sell
17
-17
-50% -$6.28K ﹤0.01% 876
2023
Q3 		$11.8K Buy
+34
New +$11.9K ﹤0.01% 750
2023
Q1 		$11K Hold
34
– – ﹤0.01% 793
2022
Q4 		$9K Buy
34
+1
+3% +$305 0.01% 244
2022
Q3 		$9K Buy
+33
New +$9.49K ﹤0.01% 766

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's VRTX Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 44 shares — an estimated $20K sold.

Householder Group Estate & Retirement Specialist first reported a position in VRTX in Q3 2022 and held it in 8 quarters. The position peaked at $22K in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 44 Vertex Pharmaceuticals shares in Q4 2024, an estimated $20K.
  • Householder Group Estate & Retirement Specialist first reported a position in Vertex Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Householder Group Estate & Retirement Specialist's Vertex Pharmaceuticals position peaked at $22K in Q2 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.